James McCann Biography and Net Worth

Director of Amyris

Mr. McCann is the founder and Chairman of the board of directors of 1-800-FLOWERS.COM, Inc., a floral and gourmet foods gift retailer and distribution company founded in 1976, and served as chief executive officer of 1-800-FLOWERS.COM, Inc. from 1976 until June 2016. Mr. McCann also serves on the board of directors of International Game Technology PLC and has previously served on the board of directors of Willis Towers Watson PLC and The Scotts Miracle-Gro Company.

Chair of the Leadership, Development, Inclusion and Compensation Committee
Member of the Nominating and Governance Committee

What is James F. McCann's net worth?: The estimated net worth of James F. McCann is at least $0.00 as of September 1st, 2020. Mr. McCann owns 733,428 shares of Amyris stock worth more than $0 as of April 26th. This net worth estimate does not reflect any other assets that Mr. McCann may own. Learn More about James F. McCann's net worth.
How do I contact James F. McCann?: The corporate mailing address for Mr. McCann and other Amyris executives is 5885 HOLLIS STREET SUITE 100, EMERYVILLE CA, 94608. Amyris can also be reached via phone at (510) 450-0761 and via email at [email protected]. Learn More on James F. McCann's contact information.
Has James F. McCann been buying or selling shares of Amyris?: James F. McCann has not been actively trading shares of Amyris over the course of the past ninety days. Most recently, on Monday, December 6th, James F. Mccann bought 17,400 shares of Amyris stock. The stock was acquired at an average cost of $5.71 per share, with a total value of $99,354.00. Learn More on James F. McCann's trading history.
Who are Amyris' active insiders?: Amyris' insider roster includes Eduardo Alvarez (COO), Anthony Hughes (CAO), Nicole Kelsey (Insider), Hermanus Kieftenbeld (CFO), Frank Kung (Director), James McCann (Director), and John Melo (CEO). Learn More on Amyris' active insiders.
Are insiders buying or selling shares of Amyris?: During the last year, insiders at the biotechnology company sold shares 1 times. They sold a total of 20,999 shares worth more than $19,949.05. The most recent insider tranaction occured on June, 2nd when CFO Hermanus Kieftenbeld sold 20,999 shares worth more than $19,949.05. Insiders at Amyris own 36.3% of the company. Learn More about insider trades at Amyris.
Information on this page was last updated on 6/2/2023.

James F. McCann Insider Trading History at Amyris

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/6/2021	Buy	17,400	$5.71	$99,354.00

James F. McCann Buying and Selling Activity at Amyris

Amyris Company Overview

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Today's Range

Now: N/A

50 Day Range

MA: $0.54

$0.05

$1.17

2 Week Range

Now: N/A

Volume

46,746,000 shs

Average Volume

12,593,118 shs

Market Capitalization

$18.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Move Your Money Before May 1

From Stansberry Research | Ad

Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?

Click here to get the full story before May 1.